C. Michael Gibson, M.D.
C. Michael Gibson, M.D.
Harvard Medical School
Adresse e-mail validée de bidmc.harvard.edu - Page d'accueil
Citée par
Citée par
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
Prasugrel versus clopidogrel in patients with acute coronary syndromes
SD Wiviott, E Braunwald, CH McCabe, G Montalescot, W Ruzyllo, ...
New England Journal of Medicine 357 (20), 2001-2015, 2007
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ...
Circulation 123 (23), 2736-2747, 2011
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
CP Cannon, WS Weintraub, LA Demopoulos, R Vicari, MJ Frey, N Lakkis, ...
New England Journal of Medicine 344 (25), 1879-1887, 2001
TIMI frame count: a quantitative method of assessing coronary artery flow
CM Gibson, CP Cannon, WL Daley, JT Dodge Jr, B Alexander, SJ Marble, ...
Circulation 93 (5), 879-888, 1996
Rivaroxaban in patients with a recent acute coronary syndrome
JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ...
New England Journal of Medicine 366 (1), 9-19, 2012
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
CP Cannon, CM Gibson, CT Lambrew, DA Shoultz, D Levy, WJ French, ...
Jama 283 (22), 2941-2947, 2000
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction
JM Hare, JH Traverse, TD Henry, N Dib, RK Strumpf, SP Schulman, ...
Journal of the American College of Cardiology 54 (24), 2277-2286, 2009
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
TD Henry, BH Annex, GR McKendall, MA Azrin, JJ Lopez, FJ Giordano, ...
Circulation 107 (10), 1359-1365, 2003
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised …
G Montalescot, SD Wiviott, E Braunwald, SA Murphy, CM Gibson, ...
The Lancet 373 (9665), 723-731, 2009
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
CM Gibson, CP Cannon, SA Murphy, KA Ryan, R Mesley, SJ Marble, ...
Circulation 101 (2), 125-130, 2000
Prevention of bleeding in patients with atrial fibrillation undergoing PCI
CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ...
New England Journal of Medicine 375 (25), 2423-2434, 2016
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
MS Sabatine, DA Morrow, JA de Lemos, CM Gibson, SA Murphy, N Rifai, ...
Circulation 105 (15), 1760-1763, 2002
Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial
EM Antman, RP Giugliano, CM Gibson, CH McCabe, P Coussement, ...
Circulation 99 (21), 2720-2732, 1999
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
Jama 294 (10), 1224-1232, 2005
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American College of Cardiology 75 (23), 2950-2973, 2020
Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning?
RA Kloner, T Shook, K Przyklenk, VG Davis, L Junio, RV Matthews, ...
Circulation 91 (1), 37-45, 1995
Incidence and treatment of'no-reflow'after percutaneous coronary intervention.
RN Piana, GY Paik, M Moscucci, DJ Cohen, CM Gibson, AD Kugelmass, ...
circulation 89 (6), 2514-2518, 1994
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20